ストックスクリーナーアプリを入手
45.45
0.61%
-0.28
Bristol Myers Squibb Co (BMY) 最新ニュース
Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks - Yahoo
Bristol Myers Squibb Stock Hits Day High with Strong Intraday Performance - Markets Mojo
How Bristol Myers Squibb Company (BRM) stock performs during market turbulenceRisk Management & Fast Moving Market Watchlists - newser.com
Bristol-Myers Squibb, Takeda, Astex Join AI Consortium to Train OpenFold3 for Accelerated Drug Discovery - Insider Monkey
Layoff Tracker: CSL Vifor, Bolt Cut Staff - BioSpace
PTAB Condemns Bristol-Myers' 'Whac-A-Mole Strategy' - Law360
11 Best Affordable Dividend Stocks to Buy Now - Insider Monkey
Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors - MarketWatch
These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap - Benzinga
Bristol-Myers retirees win round in lawsuit over $2B Athene annuity deal - InsuranceNewsNet
Bristol Myers Alzheimer's Drug Earns FDA Fast Track - Yahoo
Bristol-Myers Squibb Co (BMY) Stock Price, Trades & News - GuruFocus
Bristol-Myers Squibb (BMY) Reports Strong Multiple Myeloma Data - Insider Monkey
Bristol-Myers Squibb Company (BMY) Begins Selling Its Psoriasis Medication Sotyktu Directly to Cash-Paying U.S. Customers - Insider Monkey
Judge Lets Core Claims Proceed in PRT Case Against Bristol-Myers Squibb - plansponsor
FDA grants fast track designation for Alzheimer’s drug BMS-986446 - Investing.com India
Major Alzheimer's Breakthrough: BMS-Prothena Drug Gets FDA Fast Track for Targeting Tau Protein - Stock Titan
Bristol Myers Squibb Co. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Ex-Dividend Reminder: Quest Diagnostics, Bristol Myers Squibb and Globe Life - Nasdaq
Bristol Myers (BMY) Receives Fast Track Status for Alzheimer's T - GuruFocus
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields - Benzinga
FDA grants fast track designation for Bristol Myers Squibb’s Alzheimer’s drug - Investing.com Nigeria
Bristol Myers Squibb (BMY) Joins Consortium for AI Drug Discover - GuruFocus
BMYBristol-Myers Squibb Co Latest Stock News & Market Updates - Stock Titan
Big pharma firms announce direct-to-consumer sales and price cuts in U.S. - Reuters
Bristol Myers, Takeda to pool data for AI-based drug discovery By Reuters - Investing.com
Bristol Myers, Takeda to pool data for AI-based drug discovery - Yahoo
Judge denies motions by Bristol-Myers Squibb, State Street IM to dismiss PRT lawsuit - Pensions & Investments
Bernstein Maintains a Hold on Bristol-Myers Squibb Company (BMY) - Insider Monkey
Bristol Myers Squibb call volume above normal and directionally bullish - TipRanks
Multiple Modalities in the Oncology Market Size, Regional Growth and Trends - GlobeNewswire Inc.
Bristol-Myers Retirees’ Pension De-Risking Suit Moves Forward - Bloomberg Law News
Bristol Myers Squibb Company $BMY Position Cut by Capital Investment Advisors LLC - MarketBeat
Is this a good reentry point in Bristol Myers Squibb Company Equity Right2025 Trading Recap & AI Driven Price Predictions - newser.com
Bristol-Myers Squibb Company (BMY) to Capitalize on Cell Therapy Edge to Pursue CAR-T Treatment Opportunities - Insider Monkey
Will Bristol Myers Squibb Company stock boost dividends further2025 Technical Overview & Accurate Entry and Exit Point Alerts - newser.com
AbbVie to launch ovarian cancer drug in UK at US price - Reuters
How Bristol-Myers Squibb Company (BMY) Delivers Strong Yields Even in Tough Markets - Insider Monkey
JLL: Bristol Myers Squibb eyes sale, partial leaseback of 1.2 million sq. ft. Summit campus - RE-NJ
Using AI based signals to follow Bristol Myers Squibb CompanyJuly 2025 Earnings & Risk Adjusted Buy and Sell Alerts - newser.com
Bristol-Myers Squibb Company (BMY) Stock Analysis: 20% Upside Potential Amid Strong Dividend Yield - DirectorsTalk Interviews
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It - sharewise.com
Fort Washington Investment Advisors Inc. OH Acquires 7,095 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
KG&L Capital Management LLC Buys 39,136 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Is Bristol Myers Squibb Company Celegne Contingent stock inflation resilientWeekly Trend Recap & Verified Short-Term Trading Plans - newser.com
Why Bristol-Myers Squibb (BMY) Deserves a Spot in Passive Income Portfolios - Insider Monkey
Perigon Wealth Management LLC Has $2.48 Million Holdings in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Position Trimmed by TD Private Client Wealth LLC - MarketBeat
Trump's Drug Tariffs 'A Meaningful Commercial Hit' For Americans, Says AnalystEli Lilly (NYSE:LLY), Bristol-Myers Squibb (NYSE:BMY) - Benzinga
Bristol Myers Squibb discovers new TLR7 agonists - BioWorld MedTech
Can swing trading help recover from Bristol Myers Squibb Company losses2025 Historical Comparison & AI Powered Buy and Sell Recommendations - newser.com
BMS adds discounted psoriasis drug to its DTC channel - pharmaphorum
Meyer Handelman Co. Has $24.44 Million Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
BMS Expands Patient Options With Direct-to-Patient Platform - Dermatology Times
Bristol Myers’ Top Doctor Exits in Midst of Search for New Hit Drug - MSN
Bristol Myers Squibb to Offer More Than 80% off Sotyktu List Price - Managed Healthcare Executive
Bristol Myers Squibb leans into direct-to-consumer with telehealth launch, drug price drop - eMarketer
Bristol Myers To Sell Plaque Psoriasis Drug For Over 80% Discount Starting In 2026 - Stocktwits
Bristol Myers to sell psoriasis drug at over 80% discount to some US patients - Reuters
BMS expands DTC offering with Sotyktu addition - Pharmaceutical Technology
PGIM Jennison Health Sciences Fund Sold its Position in Bristol-Myers Squibb Co. (BMY) in Q2 - Insider Monkey
Bristol Myers Squibb (BMY) Expands Discounted Drug Offerings - GuruFocus
Bristol Myers (BMY) Expands Direct Patient Access to Key Medicat - GuruFocus
Bristol Myers expands DTC offerings (BMY:NYSE) - Seeking Alpha
1.52%
0.36%
大文字化:
|
ボリューム (24 時間):